InFlectis BioScience
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Treatment Combining Riluzole and IFB-088 in Bulbar Amyotrophic Lateral Sclerosis (TRIALS Protocol) (NCT05508074) | InFlectis BioScience | 2022-12-02 |
| A Combined SAD and MAD Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of IFB-088 (NCT03610334) | InFlectis BioScience | 2018-06-21 |
Track InFlectis BioScience automatically
Every clearance here is in the API, with alerts when new ones post.